Tripamide
As of the edition of 20 October 2026, Tripamide is a small molecule: marketed.
Sources: FDA Orange Book and Purple Book, other approval registers, ClinicalTrials.gov, ChEMBL.
The drug
- Status
- Marketed
- Kind
- Small molecule
- Approvals on record
- 1 in 1 region
- Holder of the most recent approval
- Eisai
US protection
No US approval on record.
With no US approval on record there are no listed US patents or exclusivities.
This is the US only.
Who has held its approvals
| Company | Role | Years |
|---|---|---|
| Eisai | Originator |